1st Department of Internal Medicine, General Hospital of Athens GENNIMATAS
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Adamis, Georgios
REACT, NCT06294600: Clarithromycin Treatment to Prevent Sepsis Progression in CAP

Recruiting
3
330
Europe
Clarithromycin 500mg, A β-lactam/β-lactamase inhibitor or a 3rd generation cephalosporin or a fluoroquinolone, Tablets
Hellenic Institute for the Study of Sepsis
Community-acquired Pneumonia
11/25
01/26
MODIFY, NCT05909683: Assessing the Procalcitonin-guidance and Molecular-guided Diagnosis for Therapy of Severe Infections (the Trial)

Recruiting
3
190
Europe
Change of antimicrobials based on BCID2 and Reveal Rapid AST tests. Stop of antimicrobials based on PCT results., Standard of Care
Hellenic Institute for the Study of Sepsis
Sepsis
07/25
07/25
INSPIRE, NCT05785442: Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia

Completed
2
60
Europe
Anakinra Prefilled Syringe, Kineret, Placebo, NaCl
Hellenic Institute for the Study of Sepsis
Community-acquired Pneumonia, Hospital-acquired Pneumonia
06/24
06/24
HOMI-LUNG CAP, NCT06601998: Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.

Recruiting
N/A
650
Europe
Blood samples and Oropharyngeal swab, Six-minute walk test, Spirometry, ECG, Heart ultrasound and cardiopulmonary exercise stress testing, Completion of questionnaires of symptoms
Hellenic Institute for the Study of Sepsis
Pneumonia, Community-Acquired, COVID-19 Pneumonia, Cardiovascular Diseases
11/27
11/27

Download Options